1
|
Liu M, Yu Q, Liu Y. Developing quality indicators for cancer hospitals in China: a national modified Delphi process. BMJ Open 2024; 14:e082930. [PMID: 38594187 PMCID: PMC11015267 DOI: 10.1136/bmjopen-2023-082930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/07/2023] [Accepted: 03/19/2024] [Indexed: 04/11/2024] Open
Abstract
OBJECTIVE Although demand and supply of cancer care have been rapidly increasing in recent decades, there is a lack of systemic quality measurement for cancer hospitals in China. This study aimed to develop a set of core indicators for measuring quality of care for cancer hospitals in China. DESIGN The development of quality indicators was based on a literature review and a two-round modified Delphi survey. The theoretical framework and initial indicators were identified through the comprehensive literature review, and the selection of quality indicators relied on experts' consensus on the importance and feasibility of indicators by the modified Delphi process. In addition, indicator weight was identified using the analytical hierarchical process method and percentage weight method. SETTING AND PARTICIPANTS A panel of leading experts including oncologists, cancer care nurses, quality management experts from various regions of China were invited to participate in the two-round modified Delphi process from October to December 2020. A total of 25 experts completed the two-round modified Delphi process. RESULTS The experts reached consensus on a set of 47 indicators, comprising 17 structure indicators, 19 process indicators and 11 outcome indicators. Experts gave much higher weight to outcome indicators (accounting for 53.96% relative weight) than to structure (16.34%) and process (29.70%) indicators. In addition, experts also showed concerns and gave suggestions on data availability of specific outcome indicators. CONCLUSIONS Drawing on the comprehensive literature review and the modified Delphi process, this study developed a core set of quality indicators that can be used to evaluate quality performance of cancer hospitals. This is helpful in supporting quality cancer care in China and will provide new insights into the systemic measurement of cancer care internationally.
Collapse
Affiliation(s)
- Meicen Liu
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| | - Qingyuan Yu
- School of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| | - Yuanli Liu
- School of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| |
Collapse
|
2
|
Kang L, Wang MH, Wu SJ. Construction of nursing-sensitive quality indicator system for cardiac rehabilitation of patients undergoing percutaneous coronary intervention based on structure-process-outcome model. BMC Nurs 2023; 22:457. [PMID: 38049804 PMCID: PMC10696800 DOI: 10.1186/s12912-023-01618-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2023] [Accepted: 11/21/2023] [Indexed: 12/06/2023] Open
Abstract
BACKGROUND Coronary heart disease (CHD) is a cardiovascular disease with high mortality. At present, percutaneous coronary intervention (PCI) is considered as the main effective treatment for CHD due to less trauma, shorter course of treatment, and better curative effect. However, PCI alone is not a permanent cure, so cardiac rehabilitation (CR) is needed for a supplement. Nowadays, the evaluation of the nursing-sensitive quality of CR after PCI focuses on the outcomes of patients, lacks a complete evaluation indicator system, and is prone to problems such as nursing management imbalance. OBJECTIVE A scientific, sensitive, comprehensive and practical nursing-sensitive quality indicator system based on the structure-process-outcome model was constructed to provide a reference for evaluating nursing-sensitive quality of CR after PCI. METHODS Firstly, through literature analysis and semi-structured interview, the indicator system was collected, screened and determined. Then, the framework of the indicator system was established, and the draft of nursing-sensitive quality indicator system of CR after PCI was formed. Subsequently, the nursing-sensitive quality indicator system of CR after PCI was initially established using Delphi method. Finally, the specific weight was determined by analytic hierarchy process (AHP), and the nursing-sensitive quality indicator system of CR after PCI was established and perfected. RESULTS Two rounds of expert consultations were separately given 15 questionnaires, and all these questionnaires were returned, with a questionnaire response rate of 100%. Such result indicated that experts were highly motivated. Besides, the authoritative coefficients for two rounds of expert consultations were 0.865 and 0.888, and the coordination coefficients were 0.491 and 0.522, respectively. Hence, the experts' authority and coordination were high and the results were reliable. After the second round of expert consultation, the nursing-sensitive quality indicator system of CR after PCI was established, eventually. This system consisted of 3 first-level indicators (structural indicator, process indicator and outcome indicator), 11 s-level indicators and 29 third-level indicators. CONCLUSION A relatively complete and reliable nursing-sensitive quality indicator system of CR after PCI has been established in this study. Such system is scientific and reliable and can provide a reference for the evaluation of clinical teaching quality of CR after PCI.
Collapse
Affiliation(s)
- Lei Kang
- Cardiovascular Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Min-Hui Wang
- Cardiovascular Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Sheng-Jia Wu
- Cardiovascular Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
| |
Collapse
|
3
|
Abutineh F, Zebin ZA, Obeidat S, Kafisheh D, Sakaan FM, Puerto-Torres M, Agulnik A, Arias AV. Improving quality of pediatric onco-critical care: A 2-year experience using PROACTIVE at a cancer center in Jordan. Pediatr Blood Cancer 2023; 70:e30637. [PMID: 37592362 DOI: 10.1002/pbc.30637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/03/2023] [Revised: 07/28/2023] [Accepted: 08/08/2023] [Indexed: 08/19/2023]
Abstract
PROACTIVE (PediatRic Oncology cApaCity Assessment Tool for IntensiVe CarE) is a consensus-derived tool that evaluates pediatric onco-critical care (POCC) services and identifies gaps amenable to improvement. King Hussein Cancer Center (KHCC), an oncology hospital in Jordan, completed PROACTIVE in 2021 and 2022. We evaluated PROACTIVE's ability to identify gaps and improve POCC services at KHCC by analyzing score changes and interviewing site leaders to understand mechanisms of improvement. Results identified three types of outcomes: direct (e.g., improved multidisciplinary communication), indirect (e.g., guidelines implementation), and other outcomes unrelated to PROACTIVE (e.g., funding mechanisms). PROACTIVE can assist institutions strengthen and monitor POCC services over time.
Collapse
Affiliation(s)
- Farris Abutineh
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | | | | | | | - Firas M Sakaan
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Maria Puerto-Torres
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Asya Agulnik
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Anita V Arias
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| |
Collapse
|
4
|
Schladerer SP, Otth M, Scheinemann K. Quality criteria for pediatric oncology centers: A systematic literature review. Cancer Med 2023; 12:18999-19012. [PMID: 37584279 PMCID: PMC10557895 DOI: 10.1002/cam4.6452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 07/20/2023] [Accepted: 08/03/2023] [Indexed: 08/17/2023] Open
Abstract
INTRODUCTION Survival of children and adolescents diagnosed with cancer improved over the last decades due to better diagnostics, treatment, and supportive care. Quality criteria that measure, compare, and make the quality of care of individual pediatric oncology centers more transparent are heterogeneous and inconsistent. AIM With this systematic review, we aimed to summarize existing quality criteria for pediatric oncology centers in countries with highly developed health-care systems. METHODS We searched three databases for publications, and websites for guidelines about quality criteria for pediatric oncology centers in February 2022. We considered all types of publications except expert opinions. We excluded publications not focusing on highly developed health-care systems, addressing the certification of professionals, or focusing on subspecialties (e.g., pediatric neuro-oncology). We discarded quality criteria if they were too specific (e.g., for a specific treatment center), too broad (e.g., national 5-year overall survival), or if the aspect was covered by standardized clinical procedures or at the national level. We grouped the identified criteria thematically. RESULTS We identified 18 publications and guideline documents with 530 criteria, of which 201 fulfilled the inclusion criteria. The combination of similar criteria resulted in 90 overarching criteria, which we assigned to the following categories: facilities and networks, multidisciplinary team and other experts, supportive care, treatment, long-term care, and volume and numbers. CONCLUSION Our results provide a comprehensive overview of existing quality criteria for pediatric oncology in countries with highly developed health-care systems. These criteria can serve as a basis to develop national quality criteria in pediatric oncology.
Collapse
Affiliation(s)
- Sarah P. Schladerer
- Faculty of Health Sciences and MedicineUniversity of LucerneLucerneSwitzerland
| | - Maria Otth
- Faculty of Health Sciences and MedicineUniversity of LucerneLucerneSwitzerland
- Pediatric Hematology‐Oncology CenterChildren's Hospital of Eastern SwitzerlandSt GallenSwitzerland
- Department of Oncology, Hematology, Immunology, Stem Cell Transplantation and Somatic Gene TherapyUniversity Children's Hospital Zurich‐Eleonore FoundationZurichSwitzerland
| | - Katrin Scheinemann
- Faculty of Health Sciences and MedicineUniversity of LucerneLucerneSwitzerland
- Pediatric Hematology‐Oncology CenterChildren's Hospital of Eastern SwitzerlandSt GallenSwitzerland
- Department of PediatricsMcMaster Children's Hospital and McMaster UniversityHamiltonCanada
| |
Collapse
|
5
|
Agulnik A, Muniz-Talavera H, Pham LTD, Chen Y, Carrillo AK, Cárdenas-Aguirre A, Gonzalez Ruiz A, Garza M, Conde Morelos Zaragoza TM, Soberanis Vasquez DJ, Méndez-Aceituno A, Acuña-Aguirre C, Alfonso-Carreras Y, Alvarez Arellano SY, Andrade Sarmiento LA, Batista R, Blasco Arriaga EE, Calderon P, Chavez Rios M, Costa ME, Díaz-Coronado R, Fing Soto EA, Gómez García WC, Herrera Almanza M, Juarez Tobías MS, León López EM, López Facundo NA, Martinez Soria RA, Miller K, Miralda Méndez ST, Mora Robles LN, Negroe Ocampo NDC, Noriega Acuña B, Osuna Garcia A, Pérez Alvarado CM, Pérez Fermin CK, Pineda Urquilla EE, Portilla Figueroa CA, Ríos Lopez LE, Rivera Mijares J, Soto Chávez V, Suarez Soto JI, Teixeira Costa J, Tejocote Romero I, Villanueva Hoyos EE, Villegas Pacheco M, Devidas M, Rodriguez-Galindo C. Effect of paediatric early warning systems (PEWS) implementation on clinical deterioration event mortality among children with cancer in resource-limited hospitals in Latin America: a prospective, multicentre cohort study. Lancet Oncol 2023; 24:978-988. [PMID: 37433316 PMCID: PMC10727097 DOI: 10.1016/s1470-2045(23)00285-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2023] [Revised: 05/23/2023] [Accepted: 06/08/2023] [Indexed: 07/13/2023]
Abstract
BACKGROUND Paediatric early warning systems (PEWS) aid in the early identification of clinical deterioration events in children admitted to hospital. We aimed to investigate the effect of PEWS implementation on mortality due to clinical deterioration in children with cancer in 32 resource-limited hospitals across Latin America. METHODS Proyecto Escala de Valoración de Alerta Temprana (Proyecto EVAT) is a quality improvement collaborative to implement PEWS in hospitals providing childhood cancer care. In this prospective, multicentre cohort study, centres joining Proyecto EVAT and completing PEWS implementation between April 1, 2017, and May 31, 2021, prospectively tracked clinical deterioration events and monthly inpatient-days in children admitted to hospital with cancer. De-identified registry data reported between April 17, 2017, and Nov 30, 2021, from all hospitals were included in analyses; children with limitations on escalation of care were excluded. The primary outcome was clinical deterioration event mortality. Incidence rate ratios (IRRs) were used to compare clinical deterioration event mortality before and after PEWS implementation; multivariable analyses assessed the correlation between clinical deterioration event mortality and centre characteristics. FINDINGS Between April 1, 2017, and May 31, 2021, 32 paediatric oncology centres from 11 countries in Latin America successfully implemented PEWS through Proyecto EVAT; these centres documented 2020 clinical deterioration events in 1651 patients over 556 400 inpatient-days. Overall clinical deterioration event mortality was 32·9% (664 of 2020 events). The median age of patients with clinical deterioration events was 8·5 years (IQR 3·9-13·2), and 1095 (54·2%) of 2020 clinical deterioration events were reported in male patients; data on race or ethnicity were not collected. Data were reported per centre for a median of 12 months (IQR 10-13) before PEWS implementation and 18 months (16-18) after PEWS implementation. The mortality rate due to a clinical deterioration event was 1·33 events per 1000 patient-days before PEWS implementation and 1·09 events per 1000 patient-days after PEWS implementation (IRR 0·82 [95% CI 0·69-0·97]; p=0·021). In the multivariable analysis of centre characteristics, higher clinical deterioration event mortality rates before PEWS implementation (IRR 1·32 [95% CI 1·22-1·43]; p<0·0001), being a teaching hospital (1·18 [1·09-1·27]; p<0·0001), not having a separate paediatric haematology-oncology unit (1·38 [1·21-1·57]; p<0·0001), and having fewer PEWS omissions (0·95 [0·92-0·99]; p=0·0091) were associated with a greater reduction in clinical deterioration event mortality after PEWS implementation; no association was found with country income level (IRR 0·86 [95% CI 0·68-1·09]; p=0·22) or clinical deterioration event rates before PEWS implementation (1·04 [0·97-1·12]; p=0·29). INTERPRETATION PEWS implementation was associated with reduced clinical deterioration event mortality in paediatric patients with cancer across 32 resource-limited hospitals in Latin America. These data support the use of PEWS as an effective evidence-based intervention to reduce disparities in global survival for children with cancer. FUNDING American Lebanese Syrian Associated Charities, US National Institutes of Health, and Conquer Cancer Foundation. TRANSLATIONS For the Spanish and Portuguese translations of the abstract see Supplementary Materials section.
Collapse
Affiliation(s)
- Asya Agulnik
- St Jude Children's Research Hospital, Memphis, TN, USA.
| | | | - Linh T D Pham
- St Jude Children's Research Hospital, Memphis, TN, USA
| | - Yichen Chen
- St Jude Children's Research Hospital, Memphis, TN, USA
| | | | | | | | - Marcela Garza
- St Jude Children's Research Hospital, Memphis, TN, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Kenia Miller
- Hospital del Niño "Jose Renan Esquivel", Panama, Panama
| | | | | | | | | | | | | | | | | | | | | | | | | | - Jorge Iván Suarez Soto
- Hospital del Niño. Sistema integral para el Desarrollo de la Familia (DIF), Pachuca, Mexico
| | | | | | | | | | | | | |
Collapse
|
6
|
Marwah H, Tripathi R, Saikia B, Anand P, Arora RS. ICU Admissions and Outcomes of Childhood Cancer Patients in Single Tertiary Hospital in the Private Sector in India. South Asian J Cancer 2023; 12:286-289. [PMID: 38047049 PMCID: PMC10691912 DOI: 10.1055/s-0042-1756283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022] Open
Abstract
Ramandeep Singh AroraBackground Modern-day treatment of childhood cancer is punctuated by the necessary need for intensive care. This study was performed to understand the intensive care unit (ICU) admission rates and factors associated with ICU admission in a cohort of newly diagnosed childhood cancer patients in India. Materials and Methods All childhood (age <18 years) patients in the hospital-based cancer registry who had registered between March 1, 2013, and May 31, 2018, formed the cohort. ICU admissions were recorded and demographic and clinical factors associated with ICU admission were investigated. ICU admission rates were the primary outcome of interest and secondary outcomes were ICU admission rates for sick/supportive reasons, ICU admission rates for surgical/procedural reasons and mortality during ICU admission. Results In a cohort of 258 children (66% males, 61% from India, and median age 7 years), 149 (58%) patients needed one or more ICU admission (median one with range of one to five) with total 204 ICU admission episodes. While age group, gender, and nationality were not significantly associated with ICU admission, cancer type was (highest in neuroblastoma (82%) and central nervous system (CNS) tumors (71%)). Sick/supportive care ICU admissions were significantly higher in patients of younger age, Indian origin, and certain cancers (leukemias, lymphomas). Surgical/procedural ICU admissions were significantly higher in international patients and certain cancers (CNS tumors, neuroblastomas, and soft tissue sarcomas). There were 17 ICU deaths (11% of patients admitted to ICU) and all but one were from sick/supportive care ICU admissions. Conclusion Our study highlights higher than reported ICU admission rates and lower than reported mortality in children with cancer in low- and middle-income countries. We next plan to develop more specific ICU admission criteria, prospectively evaluating severity metrics in these patients, and explore the development of a high dependency unit.
Collapse
Affiliation(s)
- Harleen Marwah
- School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia, United States
| | - Rashi Tripathi
- Quality Care, Research and Impact, Cankids, New Delhi, India
| | - Bhaskar Saikia
- Pediatric Intensive Care, Max Smart Super Specialty Hospital, New Delhi, India
| | - Preeti Anand
- Pediatric Intensive Care, Max Smart Super Specialty Hospital, New Delhi, India
| | | |
Collapse
|
7
|
Agulnik A. Management of septic shock in children with cancer-Common challenges and research priorities. J Pediatr (Rio J) 2023; 99:101-104. [PMID: 36706794 PMCID: PMC10031354 DOI: 10.1016/j.jped.2023.01.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Affiliation(s)
- Asya Agulnik
- St. Jude Children's Research Hospital, Memphis, TN.
| |
Collapse
|
8
|
Arias AV, Sakaan FM, Puerto-Torres M, Al Zebin Z, Bhattacharyya P, Cardenas A, Gunasekera S, Kambugu J, Kirgizov K, Libes J, Martinez A, Matinyan NV, Mendez A, Middlekauff J, Nielsen KR, Pappas A, Ren H, Sharara-Chami R, Torres SF, McArthur J, Agulnik A. Development and pilot testing of PROACTIVE: A pediatric onco-critical care capacity and quality assessment tool for resource-limited settings. Cancer Med 2023; 12:6270-6282. [PMID: 36324249 PMCID: PMC10028058 DOI: 10.1002/cam4.5395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2022] [Revised: 10/12/2022] [Accepted: 10/21/2022] [Indexed: 11/06/2022] Open
Abstract
BACKGROUND Nearly 90% children with cancer reside in low- and middle-income countries, which face multiple challenges delivering high-quality pediatric onco-critical care (POCC). We recently identified POCC quality and capacity indicators for PROACTIVE (PediatRic Oncology cApaCity assessment Tool for IntensiVe carE), a tool that evaluates strengths and limitations in POCC services. This study describes pilot testing of PROACTIVE, development of center-specific reports, and identification of common POCC challenges. METHODS The original 119 consensus-derived PROACTIVE indicators were converted into 182 questions divided between 2 electronic surveys for intensivists and oncologists managing critically ill pediatric cancer patients. Alpha-testing was conducted to confirm face-validity with four pediatric intensivists. Eleven centers representing diverse geographic regions, income levels, and POCC services conducted beta-testing to evaluate usability, feasibility, and applicability of PROACTIVE. Centers' responses were scored and indicators with mean scores ≤75% in availability/performance were classified as common POCC challenges. RESULTS Alpha-testing ensured face-validity and beta-testing demonstrated feasibility and usability of PROACTIVE (October 2020-June 2021). Twenty-two surveys (response rate 99.4%) were used to develop center-specific reports. Adjustments to PROACTIVE were made based on focus group feedback and surveys, resulting in 200 questions. Aggregated data across centers identified common POCC challenges: (1) lack of pediatric intensivists, (2) absence of abstinence and withdrawal symptoms monitoring, (3) shortage of supportive care resources, and (4) limited POCC training for physicians and nurses. CONCLUSIONS PROACTIVE is a feasible and contextually appropriate tool to help clinicians and organizations identify challenges in POCC services across a wide range of resource-levels. Widespread use of PROACTIVE can help prioritize and develop tailored interventions to strengthen POCC services and outcomes globally.
Collapse
Affiliation(s)
- Anita V Arias
- Division of Critical Care, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Firas M Sakaan
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Maria Puerto-Torres
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Zebin Al Zebin
- Pediatric Hematology and Oncology, King Hussein Cancer Center, Amman, Jordan
| | | | - Adolfo Cardenas
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Sanjeeva Gunasekera
- Department of Pediatric Oncology, National Cancer Institute Sri Lanka, Maharagama, Sri Lanka
| | - Joyce Kambugu
- Department of Pediatric Oncology, Uganda Cancer Institute, Kampala, Uganda
| | | | - Jaime Libes
- Department of Pediatric Hematology and Oncology, University of Illinois College of Medicine, Peoria, Illinois, USA
| | - Angelica Martinez
- Pediatric Hemato-Oncology Unit, Hospital General de Tijuana, Tijuana, Baja California, Mexico
| | | | - Alejandra Mendez
- Pediatric Critical Care, Unidad Nacional de Oncología Pediátrica (UNOP), Guatemala City, Guatemala
| | - Janet Middlekauff
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Katie R Nielsen
- Division of Pediatric Critical Care, University of Washington, Seattle, Washington, USA
- Department of Global Health, University of Washington, Seattle, Washington, USA
| | - Andrew Pappas
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Hong Ren
- Department of Pediatric Intensive Care Unit, Shanghai Children's Medical Center, Shanghai, China
| | - Rana Sharara-Chami
- Department of Pediatric and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
| | - Silvio F Torres
- Pediatric Intensive Care Unit, Hospital Universitario Austral, Buenos Aires, Argentina
| | - Jennifer McArthur
- Division of Critical Care, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Asya Agulnik
- Division of Critical Care, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| |
Collapse
|
9
|
Diagnostic, Management, and Research Considerations for Pediatric Acute Respiratory Distress Syndrome in Resource-Limited Settings: From the Second Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med 2023; 24:S148-S159. [PMID: 36661443 DOI: 10.1097/pcc.0000000000003166] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
OBJECTIVES Diagnosis of pediatric acute respiratory distress syndrome (PARDS) in resource-limited settings (RLS) is challenging and remains poorly described. We conducted a review of the literature to optimize recognition of PARDS in RLS and to provide recommendations/statements for clinical practice and future research in these settings as part of the Second Pediatric Acute Lung Injury Consensus Conference (PALICC-2). DATA SOURCES MEDLINE (Ovid), Embase (Elsevier), and CINAHL Complete (EBSCOhost). STUDY SELECTION We included studies related to precipitating factors for PARDS, mechanical ventilation (MV), pulmonary and nonpulmonary ancillary treatments, and long-term outcomes in children who survive PARDS in RLS. DATA EXTRACTION Title/abstract review, full-text review, and data extraction using a standardized data collection form. DATA SYNTHESIS The Grading of Recommendations Assessment, Development, and Evaluation approach was used to identify and summarize evidence and develop recommendations. Seventy-seven studies were identified for full-text extraction. We were unable to identify any literature on which to base recommendations. We gained consensus on six clinical statements (good practice, definition, and policy) and five research statements. Clinicians should be aware of diseases and comorbidities, uncommon in most high-income settings, that predispose to the development of PARDS in RLS. Because of difficulties in recognizing PARDS and to avoid underdiagnosis, the PALICC-2 possible PARDS definition allows exclusion of imaging criteria when all other criteria are met, including noninvasive metrics of hypoxemia. The availability of MV support, regular MV training and education, as well as accessibility and costs of pulmonary and nonpulmonary ancillary therapies are other concerns related to management of PARDS in RLS. Data on long-term outcomes and feasibility of follow-up in PARDS survivors from RLS are also lacking. CONCLUSIONS To date, PARDS remains poorly described in RLS. Clinicians working in these settings should be aware of common precipitating factors for PARDS in their patients. Future studies utilizing the PALICC-2 definitions are urgently needed to describe the epidemiology, management, and outcomes of PARDS in RLS.
Collapse
|
10
|
Abutineh F, Graetz DE, Muniz-Talavera H, Ferrara G, Puerto-Torres M, Chen Y, Gillipelli SR, Elish P, Gonzalez-Ruiz A, Alfonso Carreras Y, Alvarez S, Arce Cabrera D, Arguello Vargas D, Armenta Cruz M, Barra C, Calderon Sotelo P, Carpio Z, Chavez Rios M, Covarrubias D, de Leon Vasquez L, Diaz Coronado R, Fing Soto EA, Gomez-Garcia W, Hernandez C, Juarez Tobias MS, Leon E, Loeza Oliva JDJ, Mendez A, Miller K, Montalvo Cozar E, Negroe Ocampo NDC, Penafiel E, Pineda E, Rios L, Rodriguez Ordonez E, Soto Chavez V, Devidas M, Agulnik A. Impact of hospital characteristics on implementation of a Pediatric Early Warning System in resource-limited cancer hospitals. Front Oncol 2023; 13:1122355. [PMID: 37207162 PMCID: PMC10189109 DOI: 10.3389/fonc.2023.1122355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2022] [Accepted: 04/17/2023] [Indexed: 05/21/2023] Open
Abstract
Background Pediatric Early Warning Systems (PEWS) aid in identification of deterioration in hospitalized children with cancer but are underutilized in resource-limited settings. Proyecto EVAT is a multicenter quality improvement (QI) collaborative in Latin America to implement PEWS. This study investigates the relationship between hospital characteristics and time required for PEWS implementation. Methods This convergent mixed-methods study included 23 Proyecto EVAT childhood cancer centers; 5 hospitals representing quick and slow implementers were selected for qualitative analysis. Semi-structured interviews were conducted with 71 stakeholders involved in PEWS implementation. Interviews were recorded, transcribed and translated to English, then coded using a priori and novel codes. Thematic content analysis explored the impact of hospital characteristics and QI experience on time required for PEWS implementation and was supplemented by quantitative analysis exploring the relationship between hospital characteristics and implementation time. Results In both quantitative and qualitative analysis, material and human resources to support PEWS significantly impacted time to implementation. Lack of resources produced various obstacles that extended time necessary for centers to achieve successful implementation. Hospital characteristics, such as funding structure and type, influenced PEWS implementation time by determining their resource-availability. Prior hospital or implementation leader experience with QI, however, helped facilitate implementation by assisting implementers predict and overcome resource-related challenges. Conclusions Hospital characteristics impact time required to implement PEWS in resource-limited childhood cancer centers; however, prior QI experience helps anticipate and adapt to resource challenges and more quickly implement PEWS. QI training should be a component of strategies to scale-up use of evidence-based interventions like PEWS in resource-limited settings.
Collapse
Affiliation(s)
- Farris Abutineh
- Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN, United States
| | - Dylan E. Graetz
- Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN, United States
| | - Hilmarie Muniz-Talavera
- Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN, United States
| | - Gia Ferrara
- Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN, United States
| | - Maria Puerto-Torres
- Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN, United States
| | - Yichen Chen
- Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN, United States
| | | | - Paul Elish
- Rollins School of Public Health, Emory University, Atlanta, GA, United States
| | | | | | - Shillel Alvarez
- Pediatric Oncology, Benemérito Hospital General con Especialidades “Juan María de Salvatierr”, La Paz, Mexico
| | - Daniela Arce Cabrera
- Pediatric Hemato-Oncology Unit, Hospital Pediatrico de Sinaloa, Culiacan, Mexico
| | | | | | - Camila Barra
- Pediatric Oncology, Centro de Investigacion Bradford Hill, Santiago, Chile
| | | | - Zulma Carpio
- Pediatric Oncology, Instituto Nacional de Enfermedades Neoplasticas, Lima, Peru
| | | | - Daniela Covarrubias
- Pediatric Oncology, Centro Estatal de Oncología de Campeche, Campeche, Mexico
| | - Lucy de Leon Vasquez
- Pediatric Oncology, Hospital Infantil Regional Universitario Dr. Arturo Grullon, Santiago, Dominican Republic
| | | | | | - Wendy Gomez-Garcia
- Oncology Unit, Hospital Infantil Dr. Robert Reid Cabral, Santo, Domingo, Dominican Republic
| | | | | | - Esmeralda Leon
- Medical Oncology, Hospital Guillermo Almenara Irigoyen, Lima, Peru
| | | | - Alejandra Mendez
- Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN, United States
| | - Kenia Miller
- Pediatric Hemato-Oncology, Hospital del Niño “Jose Renan Esquivel”, Panama City, Panama
| | - Erika Montalvo Cozar
- Pediatric Intensive Care Unit, Hospital Oncológico Solca Núcleo de Quito, Quito, Ecuador
| | | | - Eulalia Penafiel
- Pediatric Oncology, Instituto del Cáncer SOLCA Cuenca, Cuenca, Ecuador
| | - Estuardo Pineda
- Pediatric Hemato-Oncology, Hospital Nacional de Niños Benjamín Bloom, San Salvador, El Salvador
| | - Ligia Rios
- Pediatric Hemato-Oncology, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
| | | | | | - Meenakshi Devidas
- Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN, United States
| | - Asya Agulnik
- Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN, United States
- *Correspondence: Asya Agulnik,
| |
Collapse
|
11
|
Sullivan CE, Day SW, Ivankova N, Markaki A, Patrician PA, Landier W. Establishing nursing-sensitive quality indicators for pediatric oncology: An international mixed methods Delphi study. J Nurs Scholarsh 2023; 55:388-400. [PMID: 35790072 PMCID: PMC9946155 DOI: 10.1111/jnu.12798] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Revised: 05/02/2022] [Accepted: 06/17/2022] [Indexed: 01/04/2023]
Abstract
INTRODUCTION Nursing-sensitive indicators (NSIs) measure factors influencing nursing care quality and patient outcomes. Established NSIs reflect general and select specialty nursing practices. However, a core set of NSIs for international pediatric oncology nursing practice does not currently exist. Without valid and reliable quality indicators, the impact of nursing care on children and adolescents with cancer cannot be effectively measured and improved. The purpose of this study was to develop a preliminary core set of NSIs for international pediatric oncology nursing that would be important, actionable, and feasible to measure across varied resource settings and countries. DESIGN/METHODS A multiphase sequential mixed methods research design, intersected with a classical Delphi method, was utilized. Through purposive snowball sampling, 122 expert pediatric oncology nurses from 43 countries participated. Round One: Panelists identified five potential NSIs and constructs. Open-ended responses were coded and categorized through descriptive content analysis and integrated into the next round. Round Two: Panelists selected their top 10 NSIs and constructs and ranked them by importance to patient care quality. Mean importance scores were calculated through reverse scoring; the top 10 NSIs and constructs were integrated into the next round. Round Three: Panelists ranked the top 10 NSIs and constructs by order of importance for this particular population, then rated each NSI/Construct for actionability and feasibility of measurement by Likert-scale. Rounds Two and Three were analyzed using descriptive statistics. Mixed methods meta-inferences were derived from the integration of Rounds One and Three findings. RESULTS Eighty-five (70%) panelists from 38 countries completed all Delphi survey rounds. The preliminary core set of NSIs and constructs identified by the expert panel, and ranked in order of importance, were as follows: safe chemotherapy administration and handling, infection prevention/control, pediatric oncology nursing orientation program, early warning score system/recognition of patient deterioration, chemotherapy/biotherapy education/course, pain assessment/management, symptom assessment/management, patient and family education, palliative/end of life care, and continuing nursing education/competency. All NSIs and constructs were rated as actionable; all but palliative/end of life care were rated as feasible to measure. Each of the 10 NSIs and constructs were nominated in Round One by at least one expert panelist from low- and middle-income and high-income countries, and at least one panelist from the Americas. CONCLUSION Preliminary core NSIs and constructs provide insight into common attributes of international pediatric oncology nursing practice that are important, actionable, and feasible for quality measurement. CLINICAL RELEVANCE NSIs have the potential to drive quality improvement, guide comparison with other institutions, promote knowledge-sharing, and advance pediatric oncology nursing outcomes around the world. These NSIs and constructs may also be relevant to other pediatric and adult oncology settings.
Collapse
Affiliation(s)
- Courtney E. Sullivan
- School of Nursing, University of Alabama at Birmingham
- Center for Outcomes and Effectiveness Research, School of Medicine, University of Alabama at Birmingham
| | - Sara W. Day
- College of Nursing, University of Tennessee Health Science Center
| | | | | | | | - Wendy Landier
- School of Nursing, University of Alabama at Birmingham
- Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham
| |
Collapse
|
12
|
Agulnik A, Mahadeo KM, Steiner ME, McArthur JA. Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant - how far we have come and how much further we must go. Front Oncol 2023; 13:1148321. [PMID: 36910613 PMCID: PMC9992885 DOI: 10.3389/fonc.2023.1148321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Accepted: 01/23/2023] [Indexed: 02/24/2023] Open
Affiliation(s)
- Asya Agulnik
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.,Division of Critical Care, Department of Pediatrics, St. Jude Children's Research Hospital, Memphis, TN, United States
| | - Kris M Mahadeo
- Division of Pediatric Transplantation and Cellular Therapy, Duke University School of Medicine, Durham, NC, United States
| | - Marie E Steiner
- Division of Pediatric Hematology Oncology, M Health Fairview Masonic Children's Hospital, Minneapolis, MN, United States
| | - Jennifer Ann McArthur
- Division of Critical Care, Department of Pediatrics, St. Jude Children's Research Hospital, Memphis, TN, United States
| |
Collapse
|
13
|
Agulnik A, Gonzalez Ruiz A, Muniz‐Talavera H, Carrillo AK, Cárdenas A, Puerto‐Torres MF, Garza M, Conde T, Soberanis Vasquez DJ, Méndez Aceituno A, Acuña Aguirre C, Alfonso Y, Álvarez Arellano SY, Argüello Vargas D, Batista R, Blasco Arriaga EE, Chávez Rios M, Cuencio Rodríguez ME, Fing Soto EA, Gómez‐García W, Guillén Villatoro RH, Gutiérrez Rivera MDL, Herrera Almanza M, Jimenez Antolinez YV, Juárez Tobias MS, López Facundo NA, Martínez Soria RA, Miller K, Miralda S, Morales R, Negroe Ocampo N, Osuna A, Pascual Morales C, Pérez Fermin CK, Pérez Alvarado CM, Pineda E, Andrés Portilla C, Rios López LE, Rivera J, Sagaón Olivares AS, Saguay Tacuri MC, Salas Mendoza BT, Solano Picado I, Soto Chávez V, Tejocote Romero I, Tatay D, Teixeira Costa J, Villanueva E, Villegas Pacheco M, McKay VR, Metzger ML, Friedrich P, Rodriguez‐Galindo C. Model for regional collaboration: Successful strategy to implement a pediatric early warning system in 36 pediatric oncology centers in Latin America. Cancer 2022; 128:4004-4016. [PMID: 36161436 PMCID: PMC9828186 DOI: 10.1002/cncr.34427] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2022] [Revised: 06/20/2022] [Accepted: 07/11/2022] [Indexed: 01/12/2023]
Abstract
BACKGROUND Pediatric early warning systems (PEWS) aid in the early identification of deterioration in hospitalized children with cancer; however, they are under-used in resource-limited settings. The authors use the knowledge-to-action framework to describe the implementation strategy for Proyecto Escala de Valoracion de Alerta Temprana (EVAT), a multicenter quality-improvement collaborative, to scale-up PEWS in pediatric oncology centers in Latin America. METHODS Proyecto EVAT mentored participating centers through an adaptable implementation strategy to: (1) monitor clinical deterioration in children with cancer, (2) contextually adapt PEWS, (3) assess barriers to using PEWS, (4) pilot and implement PEWS, (5) monitor the use of PEWS, (6) evaluate outcomes, and (7) sustain PEWS. The implementation outcomes assessed included the quality of PEWS use, the time required for implementation, and global program impact. RESULTS From April 2017 to October 2021, 36 diverse Proyecto EVAT hospitals from 13 countries in Latin America collectively managing more than 4100 annual new pediatric cancer diagnoses successfully implemented PEWS. The time to complete all program phases varied among centers, averaging 7 months (range, 3-13 months) from PEWS pilot to implementation completion. All centers ultimately implemented PEWS and maintained high-quality PEWS use for up to 18 months after implementation. Across the 36 centers, more than 11,100 clinicians were trained in PEWS, and more than 41,000 pediatric hospital admissions had PEWS used in their care. CONCLUSIONS Evidence-based interventions like PEWS can be successfully scaled-up regionally basis using a systematic approach that includes a collaborative network, an adaptable implementation strategy, and regional mentorship. Lessons learned can guide future programs to promote the widespread adoption of effective interventions and reduce global disparities in childhood cancer outcomes. LAY SUMMARY Pediatric early warning systems (PEWS) are clinical tools used to identify deterioration in hospitalized children with cancer; however, implementation challenges limit their use in resource-limited settings. Proyecto EVAT is a multicenter quality-improvement collaborative to implement PEWS in 36 pediatric oncology centers in Latin America. This is the first multicenter, multinational study reporting a successful implementation strategy (Proyecto EVAT) to regionally scale-up PEWS. The lessons learned from Proyecto EVAT can inform future programs to promote the adoption of clinical interventions to globally improve childhood cancer outcomes.
Collapse
Affiliation(s)
- Asya Agulnik
- Department of Global Pediatric MedicineSt Jude Children’s Research HospitalMemphisTennesseeUSA
| | - Alejandra Gonzalez Ruiz
- Department of Global Pediatric MedicineSt Jude Children’s Research HospitalMemphisTennesseeUSA
| | - Hilmarie Muniz‐Talavera
- Department of Global Pediatric MedicineSt Jude Children’s Research HospitalMemphisTennesseeUSA
| | - Angela K. Carrillo
- Department of Global Pediatric MedicineSt Jude Children’s Research HospitalMemphisTennesseeUSA
| | - Adolfo Cárdenas
- Department of Global Pediatric MedicineSt Jude Children’s Research HospitalMemphisTennesseeUSA
| | - Maria F. Puerto‐Torres
- Department of Global Pediatric MedicineSt Jude Children’s Research HospitalMemphisTennesseeUSA
| | - Marcela Garza
- Department of Global Pediatric MedicineSt Jude Children’s Research HospitalMemphisTennesseeUSA
| | | | | | | | | | - Yvania Alfonso
- Pediatric Hemato‐oncologyHospital St DamienPort‐Au‐PrinceHaiti
| | | | | | - Rosario Batista
- Pediatric Hemato‐OncologyHospital Jose Domingo De ObaldíaChiriquiPanama
| | | | | | | | | | - Wendy Gómez‐García
- Pediatric Hemato‐OncologyHospital Infantil Dr Robert Reid CabralSanto DomingoDominican Republic
| | | | | | - Martha Herrera Almanza
- Pediatric Hemato‐OncologyHospital Infantil de Especialidades de ChihuahuaChihuahuaMexico
| | - Yajaira V. Jimenez Antolinez
- Pediatric Hemato‐OncologyHospital Universitario Dr José Eleuterio González, Universidad Autónoma de Nuevo LeónMonterreyMexico
| | | | - Norma Araceli López Facundo
- Pediatric Hemato‐OncologyInstituto de Seguridad Social del Estado de México y Municipos Hospital Materno InfantilTolucaMexico
| | | | - Kenia Miller
- Pediatric Hemato‐OncologyHospital del Niño “Jose Renan Esquivel”PanamaPanama
| | | | - Roxana Morales
- Pediatric Hemato‐OncologyInstituto Nacional de Enfermedades NeoplásicasLimaPeru
| | | | - Alejandra Osuna
- Pediatric Hemato‐OncologyHospital Pediátrico de SinaloaCuliacanMexico
| | | | - Clara Krystal Pérez Fermin
- Pediatric Hemato‐OncologyHospital Infantil Regional Universitario Dr Arturo GrullónSantiagoDominican Republic
| | | | - Estuardo Pineda
- Pediatric Hemato‐OncologyHospital de Niños Benjamín BloomSan SalvadorEl Salvador
| | | | | | - Jocelyn Rivera
- Department of PediatricsHospital Infantil Teletón de Oncología (HITO)QueretaroMexico
| | | | | | | | | | | | | | - Daniel Tatay
- Pediatric Hemato‐OncologyHospital del Niños de la Santísima Trinidad de CórdobaCordobaArgentina
| | | | | | | | | | - Monika L. Metzger
- Department of Global Pediatric MedicineSt Jude Children’s Research HospitalMemphisTennesseeUSA
| | - Paola Friedrich
- Department of Global Pediatric MedicineSt Jude Children’s Research HospitalMemphisTennesseeUSA
| | | | | |
Collapse
|
14
|
Schults JA, Rickard CM, Charles K, Rahiman S, Millar J, Baveas T, Long D, Kleidon TM, Macfarlane F, Mehta NM, Runnegar N, Hall L. Quality measurement and surveillance platforms in critically ill children: A scoping review. Aust Crit Care 2022:S1036-7314(22)00097-2. [PMID: 36117039 DOI: 10.1016/j.aucc.2022.07.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2022] [Revised: 07/24/2022] [Accepted: 07/31/2022] [Indexed: 10/14/2022] Open
Abstract
BACKGROUND/AIM The objective of this study was to describe current surveillance platforms which support routine quality measurement in paediatric critical care. METHOD Scoping review. The search strategy consisted of a traditional database and grey literature search as well as expert consultation. Surveillance platforms were eligible for inclusion if they collected measures of quality in critically ill children. RESULTS The search strategy identified 21 surveillance platforms, collecting 57 unique outcome (70%), process (23%), and structural (7%) quality measures. Hospital-associated infections were the most commonly collected outcome measure across all platforms (n = 11; 52%). In general, case definitions were not harmonised across platforms, with the exception of nationally mandated hospital-associated infections (e.g., central line-associated blood stream infection). Data collection relied on manual coding. Platforms typically did not provide an evidence-based rationale for measures collected, with no identifiable reports of co-designed, consensus-derived measures or consumer involvement in measure selection or prioritisation. CONCLUSIONS Quality measurement in critically ill children lacks uniformity in definition which limits local and international benchmarking. Current surveillance activities for critically ill children focus heavily on outcome measurement, with process, structural, and patient-reported measures largely overlooked. Long-term outcome measures were not routinely collected. Harmonisation of paediatric intensive care unit quality measures is needed and can be achieved using prioritisation and consensus/co-design methods.
Collapse
Affiliation(s)
- Jessica A Schults
- School of Nursing, Midwifery and Social Work, University of Queensland, St Lucia, Queensland, Australia; Metro North Hospital and Health Service, Queensland, Australia; Child Health Research Centre, Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia; School of Nursing and Midwifery Griffith University, Queensland, Australia; Paediatric Intensive Care Unit Queensland Children's Hospital, South Brisbane, Queensland, Australia.
| | - Claire M Rickard
- School of Nursing, Midwifery and Social Work, University of Queensland, St Lucia, Queensland, Australia; Metro North Hospital and Health Service, Queensland, Australia; School of Nursing and Midwifery Griffith University, Queensland, Australia
| | - Karina Charles
- School of Nursing, Midwifery and Social Work, University of Queensland, St Lucia, Queensland, Australia; Child Health Research Centre, Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia; School of Nursing and Midwifery Griffith University, Queensland, Australia; Paediatric Intensive Care Unit Queensland Children's Hospital, South Brisbane, Queensland, Australia
| | - Sarfaraz Rahiman
- Paediatric Intensive Care Unit Queensland Children's Hospital, South Brisbane, Queensland, Australia; School of Medicine, University of Queensland, St Lucia, Queensland, Australia
| | - Johnny Millar
- Paediatric Intensive Care Unit, Royal Children's Hospital, Melbourne, Victoria, Australia; Murdoch Children's Research Institute, Victoria, Australia; Department of Paediatrics, University of Melbourne, Victoria, Australia; Centre for Outcome and Resource Evaluation, Australian and New Zealand Intensive Care Society, Melbourne, Australia
| | - Thimitra Baveas
- Paediatric Intensive Care Unit Queensland Children's Hospital, South Brisbane, Queensland, Australia
| | - Debbie Long
- Paediatric Intensive Care Unit Queensland Children's Hospital, South Brisbane, Queensland, Australia; School of Nursing, Centre for Healthcare Transformation, Queensland University of Technology, Brisbane, Queensland, Australia
| | - Tricia M Kleidon
- School of Nursing, Midwifery and Social Work, University of Queensland, St Lucia, Queensland, Australia; School of Nursing and Midwifery Griffith University, Queensland, Australia; Department of Anaesthesia and Pain Management, Queensland Children's Hospital, South Brisbane, Queensland, Australia
| | - Fiona Macfarlane
- Department of Anaesthesia and Pain Management, Queensland Children's Hospital, South Brisbane, Queensland, Australia
| | - Nilesh M Mehta
- Perioperative & Critical Care Center for Outcomes Research (PC-CORE), USA; Department of Anesthesiology, Critical Care & Pain Medicine, Division of Critical Care Medicine, Boston Children's Hospital, USA; Harvard Medical School, Boston, USA
| | - Naomi Runnegar
- School of Medicine, University of Queensland, St Lucia, Queensland, Australia; Infection Management, Princess Alexandra Hospital, Woolloongabba, Qld, Australia
| | - Lisa Hall
- School of Public Health, Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia
| |
Collapse
|
15
|
Agulnik A, Cárdenas A, Carrillo AK, Bulsara P, Garza M, Alfonso Carreras Y, Alvarado M, Calderón P, Díaz R, de León C, Del Real C, Huitz T, Martínez A, Miralda S, Montalvo E, Negrín O, Osuna A, Perez Fermin CK, Pineda E, Soberanis D, Juárez Tobias MS, Lu Z, Rodriguez-Galindo C. Clinical and organizational risk factors for mortality during deterioration events among pediatric oncology patients in Latin America: A multicenter prospective cohort. Cancer 2021; 127:1668-1678. [PMID: 33524166 PMCID: PMC8248122 DOI: 10.1002/cncr.33411] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2020] [Revised: 12/02/2020] [Accepted: 12/03/2020] [Indexed: 12/12/2022]
Abstract
BACKGROUND Hospitalized pediatric hematology-oncology (PHO) patients have frequent clinical deterioration events (CDE) requiring intensive care unit (ICU) admission, particularly in resource-limited settings. The objective of this study was to describe CDEs in hospitalized PHO patients in Latin America and to identify event-level and center-level risk factors for mortality. METHODS In 2017, the authors implemented a prospective registry of CDEs, defined as unplanned transfers to a higher level of care, use of ICU-level interventions on the floor, or nonpalliative floor deaths, in 16 PHO centers in 10 countries. PHO hospital admissions and hospital inpatient days were also reported. This study analyzes the first year of registry data (June 2017 to May 2018). RESULTS Among 16 centers, 553 CDEs were reported in PHO patients during 11,536 admissions and 119,414 inpatient days (4.63 per 1000 inpatient days). Event mortality was 29% (1.33 per 1000 inpatient days) but ranged widely across centers (11%-79% or 0.36-5.80 per 1000 inpatient days). Significant risk factors for event mortality included requiring any ICU-level intervention on the floor and not being transferred to a higher level of care. Events with organ dysfunction, a higher severity of illness, and a requirement for ICU intervention had higher mortality. In center-level analysis, hospitals with a higher volume of PHO patients, less floor use of ICU intervention, lower severity of illness on transfer, and lower rates of floor cardiopulmonary arrest had lower event mortality. CONCLUSIONS Hospitalized PHO patients who experience CDEs in resource-limited settings frequently require floor-based ICU interventions and have high mortality. Modifiable hospital practices around the escalation of care for these high-risk patients may contribute to poor outcomes. Earlier recognition of critical illness and timely ICU transfer may improve survival in hospitalized children with cancer.
Collapse
Affiliation(s)
- Asya Agulnik
- Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.,Division of Critical Care, St Jude Children's Research Hospital, Memphis, Tennessee
| | - Adolfo Cárdenas
- Critical Care Medicine, Hospital Infantil Teletón de Oncología, Queretaro, Mexico
| | - Angela K Carrillo
- Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee
| | - Purva Bulsara
- Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee
| | - Marcela Garza
- Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee
| | | | - Manuel Alvarado
- Critical Care, Hospital del Niño Dr. José Renán Esquivel, Panama City, Panama
| | - Patricia Calderón
- Oncology, Hospital Infantil Manuel de Jesús Rivera, Managua, Nicaragua
| | - Rosdali Díaz
- Pediatric Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
| | - Claudia de León
- Pediatric Critical Care, Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala
| | - Claudia Del Real
- Pediatric Oncology, Benemérito Hospital General con Especialidades ¨Juan María de Salvatierra", La Paz, Mexico
| | - Tania Huitz
- Pediatric Oncology, Centro Estatal de Oncología de Campeche, Campeche, Mexico
| | | | - Scheybi Miralda
- Pediatric Critical Care, Hospital Escuela Universitario, Tegucigalpa, Honduras
| | - Erika Montalvo
- Pediatric Critical Care, Sociedad de Lucha contra el Cáncer Núcleo de Quito, Quito, Ecuador
| | - Octavia Negrín
- Hematology, Hospital Infantil Dr. Robert Reid Cabral, Santo Domingo, Dominican Republic
| | - Alejandra Osuna
- Hematology/Oncology, Hospital Pediátrico de Sinaloa, Sinaloa, Mexico
| | - Clara Krystal Perez Fermin
- Hematology/Oncology, Hospital Infantil Regional Universitario Dr. Arturo Guillón, Santiago, Dominican Republic.,Biomedical and Clinical Research Center, Santiago, Dominican Republic
| | - Estuardo Pineda
- Oncology, Hospital Nacional de Niños Benjamín Bloom, San Salvador, El Salvador
| | - Dora Soberanis
- Hematology/Oncology, Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala
| | | | - Zhaohua Lu
- Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee
| | - Carlos Rodriguez-Galindo
- Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee
| | | |
Collapse
|
16
|
Arias AV, Garza M, Murthy S, Cardenas A, Diaz F, Montalvo E, Nielsen KR, Kortz T, Sharara-Chami R, Friedrich P, McArthur J, Agulnik A. Quality and capacity indicators for hospitalized pediatric oncology patients with critical illness: A modified delphi consensus. Cancer Med 2020; 9:6984-6995. [PMID: 32777172 PMCID: PMC7541142 DOI: 10.1002/cam4.3351] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Revised: 06/21/2020] [Accepted: 07/14/2020] [Indexed: 01/09/2023] Open
Abstract
Background Hospitalized pediatric hematology‐oncology (PHO) patients are at high risk for critical illness, especially in resource‐limited settings. Unfortunately, there are no established quality indicators to guide institutional improvement for these patients. The objective of this study was to identify quality indicators to include in PROACTIVE (PediatRic Oncology cApaCity assessment Tool for IntensiVe carE), an assessment tool to evaluate the capacity and quality of pediatric critical care services offered to PHO patients. Methods A comprehensive literature review identified relevant indicators in the areas of structure, performance, and outcomes. An international focus group sorted potential indicators using the framework of domains and subdomains. A modified, three‐round Delphi was conducted among 36 international experts with diverse experience in PHO and critical care in high‐resource and resource‐limited settings. Quality indicators were ranked on relevance and actionability via electronically distributed surveys. Results PROACTIVE contains 119 indicators among eight domains and 22 subdomains, with high‐median importance (≥7) in both relevance and actionability, and ≥80% evaluator agreement. The top five indicators were: (a) A designated PICU area; (b) Availability of a pediatric intensivist; (c) A PHO physician as part of the primary team caring for critically ill PHO patients; (d) Trained nursing staff in pediatric critical care; and (e) Timely PICU transfer of hospitalized PHO patients requiring escalation of care. Conclusions PROACTIVE is a consensus‐derived tool to assess the capacity and quality of pediatric onco‐critical care in resource‐limited settings. Future endeavors include validation of PROACTIVE by correlating the proposed indicators to clinical outcomes and its implementation to identify service delivery gaps amenable to improvement.
Collapse
Affiliation(s)
- Anita V Arias
- Division of Pediatric Critical Care, University of Tennessee Health Science Center, Memphis, TN, USA.,Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA
| | - Marcela Garza
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA
| | - Srinivas Murthy
- Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
| | - Adolfo Cardenas
- Hospital Infantil Teletón de Oncología (HITO), Querétaro, México
| | - Franco Diaz
- Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile
| | - Erika Montalvo
- Pediatric Critical Care Unit, SOLCA Quito, Quito, Ecuador
| | - Katie R Nielsen
- Division of Pediatric Critical Care, University of Washington, Seattle, WA, USA.,Department of Global Health, University of Washington, Seattle, WA, USA
| | - Teresa Kortz
- Division of Pediatric Critical Care, University of California San Francisco, San Francisco, CA, USA
| | - Rana Sharara-Chami
- Department of Pediatric and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
| | - Paola Friedrich
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA
| | - Jennifer McArthur
- Division of Pediatric Critical Care, St. Jude Children's Research Hospital, Memphis, TN, USA
| | - Asya Agulnik
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.,Division of Pediatric Critical Care, St. Jude Children's Research Hospital, Memphis, TN, USA
| |
Collapse
|